BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 6, 2005
View Archived Issues
Cannabinoid CB2 receptor: potential target for the treatment of atherosclerosis
Read More
In vitro results further support PPARdelta as a potential target for the treatment of diabetes
Read More
Apoptosis inducers act via TIP47, a novel target for anticancer therapy
Read More
Chugai develops an apoptosis-inducing antibody for multiple myeloma / News in context
Read More
CONRAD receives funding for phase III microbicide trials
Read More
Adams Respiratory Therapeutics licenses erdosteine for U.S.
Read More
Kos acquires rights to Biovail products in cardiovascular field
Read More
NsGene closes financing round
Read More
A new 5-HT4 receptor antagonist shows promise in the treatment of urinary incontinence
Read More
Researchers assess the benefits of VEGF gene therapy in coronary artery disease
Read More
Novartis highlights pharmaceutical research strategy
Read More
Therapeutic benefits found for alagebrium in older subjects with systolic hypertension
Read More
Diachrome reported to decrease cardiovascular risk in type 2 diabetics
Read More
Measurement of skin cholesterol levels may help estimate the risk of heart disease
Read More
Miikana licenses phase II anticancer compound from Roche
Read More
Orphan drug designation for Copernicus' DNA drug for cystic fibrosis
Read More
Fujirebio Diagnostics seeks approval of Mesomark mesothelioma test
Read More
Positive effects of CX-717 in human sleep deprivation study
Read More
Celator closes USD 40 million financing
Read More
BioVex submits IND for OncoVex(GM-CSF) in malignant melanoma
Read More
Orphan drug status for Lorus Therapeutics' GTI-2040 for AML
Read More
Abbott submits sNDA for more convenient tablet formulation for Kaletra
Read More
Peregrine submits Tarvacin IND for HCV
Read More
Predix' 5-HT2B receptor antagonist enters phase I for pulmonary hypertension
Read More
Requip approved for moderate to severe primary restless legs syndrome
Read More
Recent patents report new possible treatment options anxiety, depression, psychosis, etc.
Read More
Novel therapeutic agents for diabetes claimed in recent patents
Read More
Add-on aprepitant improves antiemetic therapy in breast cancer patients
Read More